Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and the control of bone metabolism; however, growing evidence suggests that vitamin D deficiency may also have an important role in the progressive loss of renal function. Vitamin D deficiency is particularly frequent in patients with chronic kidney disease, in whom it is associated with increased mortality. Studies indicate that treatment with vitamin D analogues reduces proteinuria, suppresses the renin-angiotensin-aldosterone system (RAAS), and exerts anti-inflammatory and immunomodulatory effects. These pleiotropic effects render vitamin D a potentially interesting treatment modality for renoprotection in patients with chronic kidney disease....
Chronic kidney disease is frequent and usually responsible of mineral and bone disorder. These abno...
Vitamin D therapy is commonly prescribed for people with chronic kidney disease to improve biochemic...
Vitamin D deficiency (<20 ng/mL) and insufficiency (20–29 ng/mL) are common among patients with c...
Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and ...
Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and ...
Prevention of progressive renal function loss and its complications remains the main challenge in cl...
Prevention of progressive renal function loss and its complications remains the main challenge in cl...
In kidney disease, the progressive loss of renal capacity to produce calcitriol, the vitamin D hormo...
Vitamin D and its analogs: Do they protect against cardiovascular disease in patients with kidney di...
Vitamin D presents interesting pleiotropic effects for the CKD patient (effect and anti-inflammatory...
Update on vitamin D and its newer analogues: Actions and rationale for treatment in chronic renal fa...
Residual proteinuria, the amount of proteinuria that remains during optimally dosed renin-angiotensi...
Several studies indicate a relationship between hypovitaminosis D, survival, vascular calcification ...
Residual proteinuria, the amount of proteinuria that remains during optimally dosed renin-angiotensi...
Vitamin D (VD) is a pro-hormone essential for life in higher animals. It is present in few types of ...
Chronic kidney disease is frequent and usually responsible of mineral and bone disorder. These abno...
Vitamin D therapy is commonly prescribed for people with chronic kidney disease to improve biochemic...
Vitamin D deficiency (<20 ng/mL) and insufficiency (20–29 ng/mL) are common among patients with c...
Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and ...
Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and ...
Prevention of progressive renal function loss and its complications remains the main challenge in cl...
Prevention of progressive renal function loss and its complications remains the main challenge in cl...
In kidney disease, the progressive loss of renal capacity to produce calcitriol, the vitamin D hormo...
Vitamin D and its analogs: Do they protect against cardiovascular disease in patients with kidney di...
Vitamin D presents interesting pleiotropic effects for the CKD patient (effect and anti-inflammatory...
Update on vitamin D and its newer analogues: Actions and rationale for treatment in chronic renal fa...
Residual proteinuria, the amount of proteinuria that remains during optimally dosed renin-angiotensi...
Several studies indicate a relationship between hypovitaminosis D, survival, vascular calcification ...
Residual proteinuria, the amount of proteinuria that remains during optimally dosed renin-angiotensi...
Vitamin D (VD) is a pro-hormone essential for life in higher animals. It is present in few types of ...
Chronic kidney disease is frequent and usually responsible of mineral and bone disorder. These abno...
Vitamin D therapy is commonly prescribed for people with chronic kidney disease to improve biochemic...
Vitamin D deficiency (<20 ng/mL) and insufficiency (20–29 ng/mL) are common among patients with c...